News >

Challenges Remain Amid Rapid Advances in AML

Jessica Hergert
Published: Friday, Dec 06, 2019

Eytan M. Stein, MD, a hematologic oncologist at Memorial Sloan Kettering Cancer Center

Eytan M. Stein, MD

An explosion of approved agents has transformed the treatment paradigm in acute myeloid leukemia (AML), according to Eytan M. Stein, MD. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication